44th Annual San Antonio Breast Cancer Symposium (SABCS)

SABCS is designed to provide state-of-the-art information on the experimental biology, etiology, prevention, diagnosis, and therapy of breast cancer and premalignant breast disease, to an international audience of academic and private physicians and researchers.

SABCS welcomes attendance by informed patient advocates representing recognized patient advocacy, education & survivor support organizations.

Annual Lynn Sage Breast Cancer Symposium

Lynn Sage Breast Cancer Symposium has been called the most valuable breast cancer meeting worldwide for the practicing clinician. For over 20 years, this multidisciplinary CME event has been bringing together leading national and international medical, surgical and radiation oncologists to present, debate and evaluate cutting-edge technology and approaches in the management of breast cancer. New options are occurring in all aspects of patient care including prevention, screening, and detection, as well as in the primary treatment modalities of surgery, radiation therapy, endocrine therapy, cytotoxic chemotherapy, novel biologic therapies as well as survivorship. This symposium focuses on the multidisciplinary cooperation that is required for the management of today’s breast cancer patient.

43rd Annual San Antonio Breast Cancer Symposium (SABCS)

SABCS is designed to provide state-of-the-art information on the experimental biology, etiology, prevention, diagnosis, and therapy of breast cancer and premalignant breast disease, to an international audience of academic and private physicians and researchers.

SABCS welcomes attendance by informed patient advocates representing recognized patient advocacy, education & survivor support organizations.

Advances in Breast Cancer Research

Make plans to join leading basic, translational, and clinical investigators at the tenth AACR Special Conference on Advances in Breast Cancer Research. This year’s program will once again address basic and translational breast cancer research not typically covered in other breast cancer conferences with a more clinical agenda. Topics will include novel model systems, inflammation and the microenvironment, genomics, heterogeneity, personalized risk and prevention, and future therapies and immuno-oncology.

Annual Lynn Sage Breast Cancer Symposium

Lynn Sage Breast Cancer Symposium has been called the most valuable breast cancer meeting worldwide for the practicing clinician. For over 20 years, this multidisciplinary CME event has been bringing together leading national and international medical, surgical and radiation oncologists to present, debate and evaluate cutting-edge technology and approaches in the management of breast cancer. New options are occurring in all aspects of patient care including prevention, screening, and detection, as well as in the primary treatment modalities of surgery, radiation therapy, endocrine therapy, cytotoxic chemotherapy, novel biologic therapies as well as survivorship. This symposium focuses on the multidisciplinary cooperation that is required for the management of today’s breast cancer patient.

2nd International Invasive Lobular Breast Cancer Symposium

The University of Pittsburgh Cancer Institute (UPCI) will host the second Invasive Lobular Carcinoma (ILC) International Symposium. Clinical experts will explore ILC, the second most common type of breast cancer and the eighth most common cancer in women. The goal is to begin the process of leading research that will ultimately result in improved outcomes for patients with this disease.

ILC is often difficult to diagnose since it typically does not cause a firm or distinct breast lump. Clinical and laboratory studies of breast cancer have focused almost exclusively on the more common invasive ductal cancers (IDC). Prior to the first ILC symposium held in 2016, there has never been a focused meeting to discuss basic, translational and clinical research on ILC, which affects nearly 30,000 women each year.

The target audience for this symposium is researchers interested in lobular cancer, as well as medical, surgical, and radiation oncologists interested in the treatment of patients with invasive lobular carcinoma in situ (LCIS) or ILC. Patient advocate breakout sessions and networking opportunities will  be included in the program. Patient advocates for lobular cancer and other healthcare professionals are encouraged to attend.

12th European Breast Cancer Conference

The 12th edition of the European Breast Cancer Conference (EBCC-12) will provide a unique multidisciplinary setting for all professionals with a common interest in breast cancer to discuss, debate, inform and educate themselves about this evolving disease landscape.

This international conference is directed towards a broad audience including scientists, clinicians, patient representatives and health professionals of diverse profiles who tackle key issues facing patients throughout the continuum of the breast cancer journey.

42 Annual San Antonio Breast Cancer Symposium (SABCS)

SABCS is designed to provide state-of-the-art information on the experimental biology, etiology, prevention, diagnosis, and therapy of breast cancer and premalignant breast disease, to an international audience of academic and private physicians and researchers.

SABCS welcomes attendance by informed patient advocates representing recognized patient advocacy, education & survivor support organizations.

Komen® Charlotte Metastatic Breast Cancer Conference

Join Susan G. Komen Charlotte for our first-ever Metastatic Breast Cancer Conference. Our goal is to bring together individuals affected by metastatic breast cancer (MBC) with scientific and medical experts to learn about the latest advances in treatment, awareness and availability of clinical trials, increase quality of life, and provide an opportunity for attendees to interact with each other.

The MBC Conference will last approximately five hours, and will include breakfast and lunch, as well as speakers and a professional panel of experts addressing the following topics:

  • The latest advances in MBC treatment/ongoing research.
  • The importance and availability of MBC clinical trials using an expert in this field.
  • Topic related to psychosocial and/or quality of life challenges.

Up ↑